The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
Abstract
CONTEXT: Insulin sensitizers, including metformin and thiazolidinediones (TZDs), improve hyperinsulinemia and reproductive dysfunctions in some women with hyperandrogenism. The extent to which these agents improve hirsutism remains unclear. OBJECTIVE: Our objective was to conduct a systematic review and metaanalyses of randomized controlled trials of metformin or TZDs for the treatment of hirsutism. DATA SOURCES: We searched the following databases: MEDLINE, EMBASE, and Cochrane CENTRAL (up to May 2006). Review of reference lists and contact with hirsutism experts further identified candidate trials. STUDY SELECTION: Reviewers working independently and in duplicate, with acceptable chance-adjusted agreement (kappa = 0.72), determined trial eligibility. Eligible trials randomly assigned women with hirsutism to at least 6 months of insulin sensitizers or control and measured hirsutism outcomes. DATA EXTRACTION: Reviewers working independently and in duplicate determined the methodological quality of trials and collected data on patient characteristics, interventions, and outcomes. DATA SYNTHESIS: Of 348 candidate studies, 16 trials (22 comparisons) were eligible. The methodological quality of these trials was low. Random-effects metaanalyses showed a small decrease in Ferriman-Gallwey scores in women treated with insulin sensitizers compared with placebo [pooled weighted mean difference (WMD) of -1.5; 95% confidence interval (CI), -2.8 to -0.2; inconsistency (I(2)) = 75%]. There was no significant difference between insulin sensitizers and oral contraceptives (WMD of -0.5; CI, -5.0, 3.9; I(2) = 79%). Metformin was inferior to both spironolactone (WMD of 1.3; CI, 0.03, 2.6) and flutamide (WMD of 5.0; CI, 3.0, 7.0; I(2) = 0%). CONCLUSIONS: Imprecise and inconsistent evidence of low to very low quality suggests that insulin sensitizers provide limited or no important benefit for women with hirsutism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meta-analyses including larger number of RCTs in women with PCOS showed limited or no benefit of insulin sensitizers on hirsutism [185, 186].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [185]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Azziz, R., Ehrmann, D. A., Legro, R. S., Whitcomb, R. W., Hanley, R. M., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7375 · Cited by 537
Tang, T. H., Norman, R. J., Balen, A. H., & Lord, J. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053 · Cited by 369
Cited by
Sorted by citations
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
McCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1514916 · Cited by 643
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibáñez, L., Løbo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 511
Self-citationPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Consensus on women's health aspects of polycystic ovary syndrome (PCOS)
The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R. A., Carmina, H., Chang, R. J., Yıldız, B. O., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der396 · Cited by 368
Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 251
Obesity and Polycystic Ovary Syndrome
Vrbíková, J., & Hainer, V. (2009) · Obesity Facts · doi:10.1159/000194971 · Cited by 244
ACOG Practice Bulletin No. 194: polycystic ovary syndrome
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002656 · Cited by 231
Androgen excess: Investigations and management
Lizneva, D., Gavrilova-Jordan, L. P., Walker, W., & Azziz, R. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.05.003 · Cited by 160
Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
Karrer-Voegeli, S., Rey, F., Reymond, M. J., Meuwly, J., Gaillard, R. C., & Gómez, F. (2009) · Medicine · doi:10.1097/md.0b013e3181946a2c · Cited by 125
Shamasbi, S. G., Dehghan, P., Mohammad‐Alizadeh‐Charandabi, S., Aliasgarzadeh, A., & Mirghafourvand, M. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1648-7 · Cited by 101
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Sam, S., & Ehrmann, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4306-3 · Cited by 93
Comim, F. V., Hardy, K., & Franks, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080416 · Cited by 89
Glintborg, D., Altinok, M. L., Mumm, H., Hermann, A. P., Ravn, P., & Andersen, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1135 · Cited by 88
Treatment options for hirsutism: a systematic review and network meta-analysis
Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02052 · Cited by 82
Self-citationMedical treatment of hirsutism
Blume‐Peytavi, U., & Hahn, S. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00215.x · Cited by 77
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 75
Polycystic ovary syndrome: A review for dermatologists
Housman, E., & Reynolds, R. V. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.007 · Cited by 78
Hirsutism: an evidence-based treatment update
Somani, N., & Turvy, D. (2014) · American Journal of Clinical Dermatology · doi:10.1007/s40257-014-0078-4 · Cited by 69
Monastra, G., Unfer, V., Harrath, A. H., & Bizzarri, M. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1247797 · Cited by 71
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334.pub2 · Cited by 65
Hirsutism: Diagnosis and management
Brodell, L. A., & Mercurio, M. G. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.04.002 · Cited by 66
Luque-Ramírez, M., Nattero-Chávez, L., Ortiz Flores, A. E., & Escobar-Morreale, H. F. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx039 · Cited by 62
Endocrine evaluation of hirsutism
Mihailidis, J., Dermesropian, R., Taxel, P., Luthra, P., & Grant-Kels, J. M. (2017) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2017.02.007 · Cited by 54
Use of metformin in the treatment of polycystic ovary syndrome
Genazzani, A. D., Ricchieri, F., & Lanzoni, C. (2010) · Women's Health · doi:10.2217/whe.10.43 · Cited by 51
Shah, D., Patil, M., & On behalf of the National PCOS Working Group (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_72_18 · Cited by 51
Mazza, A., Fruci, B., Guzzi, P. H., D'Orrico, B., Malaguarnera, R., Veltri, P., Fava, A., & Belfiore, A. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.016 · Cited by 50
THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0585 · Cited by 49
Ruan, X., Kubba, A., Aguilar, A., & Mueck, A. O. (2017) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2017.1317735 · Cited by 47
Contemporary approaches to the management of polycystic ovary syndrome
Pasquali, R. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818756790 · Cited by 49
Polycystic ovary syndrome: A review for dermatologists
Buzney, E. A., Sheu, J., Buzney, C. D., & Reynolds, R. V. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.009 · Cited by 47
Síndrome do ovário policístico: abordagem dermatológica
de Moura, H. H. G., Costa, D. L. M., Bagatin, E., Sodré, C. T., & Manela‐Azulay, M. (2011) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962011000100015 · Cited by 44
Polycystic ovary syndrome: chemical pharmacotherapy
Rocca, M. L., Venturella, R., Mocciaro, R., Cello, A. D., Sacchinelli, A., Russo, V. M., Trapasso, S., Zullo, F., & Morelli, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1047344 · Cited by 41
McCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610000 · Cited by 43
Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies
Kanbour, S., & Dobs, A. S. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0020 · Cited by 38
Zuuren, E. J., & Fedorowicz, Z. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14486 · Cited by 35
Bode, D. V., Seehusen, D. A., & Baird, D. C. (2012) · PubMed · Cited by 35
Metformin in women with PCOS, Pros
Pasquali, R. (2014) · Endocrine · doi:10.1007/s12020-014-0311-1 · Cited by 33
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review
Mason, H. D., Colao, A., Blume‐Peytavi, U., Rice, S., Qureshi, A., Pellatt, L. J., Orio, F., & Atkin, S. L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03329.x · Cited by 33
Wang, F., Pan, J., Wu, Y. T., Zhu, Y., Hardiman, P. J., & Qu, F. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1700074 · Cited by 31
Koulouri, O., & Conway, G. S. (2009) · BMJ · doi:10.1136/bmj.b847 · Cited by 30
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 33
Valsamakis, G., Lois, K., Kumar, S., & Mastorakos, G. P. (2013) · HORMONES · doi:10.1007/bf03401302 · Cited by 28
Tailoring treatment for PCOS phenotypes
Papadakis, G. E., Kandaraki, E., Garidou, A., Koutsaki, M., Papalou, O., Diamanti‐Kandarakis, E., & Peppa, Μ. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1865152 · Cited by 30
Glintborg, D., Mumm, H., Altinok, M. L., Richelsen, B., Bruun, J. M., & Andersen, M. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0103-8 · Cited by 24
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Chatzis, P., Kandaraki, E., Tsourdi, E. A., Vosnakis, C., & Katsikis, I. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0039 · Cited by 24
Medical Treatment of Hirsutism in Women
Lumachi, F., & Basso, S. M. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791556005 · Cited by 21
Agrawal, N. K. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.119511 · Cited by 21
How to Diagnose and Treat Medically Women with Excessive Hair
Blume‐Peytavi, U. (2012) · Dermatologic Clinics · doi:10.1016/j.det.2012.08.009 · Cited by 20
Sciannimanico, S. M., Grimaldi, F., Vescini, F., Pergola, G. D., Iacoviello, M., Licchelli, B., Guastamacchia, E., Giagulli, V. A., & Triggiani, V. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190507125847 · Cited by 21
Current treatment for polycystic ovary syndrome: focus on adolescence
Street, M. E., Cirillo, F., Catellani, C., Dauriz, M., Lazzeroni, P., Sartori, C., & Moghetti, P. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05861-2 · Cited by 19
Targets to treat androgen excess in polycystic ovary syndrome
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 18
Chronic anovulation and the polycystic ovary syndrome
KASE, N. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.012 · Cited by 16
Diri, H., Karaburgu, S., Açmaz, B., Ünlühızarcı, K., Tanrıverdi, F., Karaca, Z., & Keleştimur, F. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1080679 · Cited by 16
Comprehensive clinical management of hirsutism
Castelo‐Branco, C., & Hidalgo, M. J. C. (2010) · Gynecological Endocrinology · doi:10.3109/09513591003686353 · Cited by 16
Suvarna, Y., Maity, N., Kalra, P., & Shivamurthy, M. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16129 · Cited by 15
Reimbursement of metformin for polycystic ovary syndrome
Milewicz, A. (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0025 · Cited by 18
Comparison of Finasteride, Metformin, and Finasteride Plus Metformin in PCOS
Diri, H. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.84 · Cited by 14
No. 350-Hirsutism: Evaluation and Treatment
Liu, K. E., Motan, T., & Claman, P. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.05.022 · Cited by 14
Maharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 14
Hyperandrogenism in menopause: a case report and literature review
Dolinko, A. V., & Ginsburg, E. S. (2015) · Fertility Research and Practice · doi:10.1186/2054-7099-1-7 · Cited by 13
Androgens and hair: a biological paradox with clinical consequences
Randall, V. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.008 · Cited by 12
Pharmacologic Treatment of Polycystic Ovary Syndrome: Alternate and Future Paths
Legro, R. S., & Martel‐Duguech, L. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603729 · Cited by 11
Fonseka, S., Wijeyaratne, C. N., Gawarammana, I., Kalupahana, N. S., Rosairo, S., Ratnatunga, N. V. I., & Kumarasiri, R. (2020) · PubMed Central · Cited by 12
Endocrine evaluation of hirsutism
Mihailidis, J., Dermesropian, R., Taxel, P., Luthra, P., & Grant-Kels, J. M. (2015) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2015.04.003 · Cited by 13
Lundgren, J. A., Kim, S. H., Solorzano, C. M. B., McCartney, C. R., & Marshall, J. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02068 · Cited by 11
Guideline No. 444: Hirsutism: Evaluation and Treatment
Elliott, J., Liu, K. E., & Motan, T. (2023) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2023.102272 · Cited by 13
Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review
Zhang, Y., Yang, K., Fan, T., Zheng, D., & Liu, H. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s506498 · Cited by 10
PCOS from Lifestyle to the Use of Inositol and Insulin Sensitizers
Genazzani, A. D., Prati, A., Despini, G., Marini, G. M. F., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-03494-2_7 · Cited by 7
Polycystic ovary syndrome: Challenges in adolescence
Oliveira, A. B. F. D., Sampaio, B., Teixeira, A., Castro-Correia, C., Fontoura, M., & Medina, J. L. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.04.007 · Cited by 6
Approach to the management of idiopathic hirsutism.
Markovski, M., Hall, J., Jin, M., Laubscher, T. A., & Regier, L. D. (2012) · PubMed Central · Cited by 6
Interventions for hirsutism excluding laser and photoepilation therapy
van Zuuren, E. J., Fedorowicz, Z., & Carter, B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334 · Cited by 6
Polycystic ovary syndrome in pediatric obesity and diabetes
DONDI, E., TUFANO, M., VIGONE, M. C., LUCACCIONI, L., POZZOBON, G., Ubertini, G., MOZZILLO, E., & Delvecchio, M. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.21.06542-3 · Cited by 5
A systematic review of the uses of metformin in dermatology
Raza, S., Al‐Niaimi, F., & Ali, F. R. (2022) · Clinical and Experimental Dermatology · doi:10.1093/ced/llac027 · Cited by 4
Updates on Hirsutism: A Narrative Review
Hussein, R., & Abdelbasset, W. K. (2022) · International Journal of Biomedicine · doi:10.21103/article12(2)_ra4 · Cited by 5
Cutaneous Manifestations of Endocrine Disease
Icecreamwala, D., & Shwayder, T. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch154 · Cited by 4
Polycystic ovary syndrome: the strategy of diagnosis and treatment
Олеговна, Д. С. (2014) · Russian Journal of Human Reproduction · doi:10.17116/repro201420610-17 · Cited by 3
Diagnosis and treatments of hirsutism: where are we?
Rashidi, M., & Sinclair, R. D. (2011) · Expert Review of Dermatology · doi:10.1586/edm.11.45 · Cited by 3
Hirsutism: from Brazil to a place near you
Yazdabadi, A., & Sinclair, R. D. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903479675 · Cited by 3
PCOS and metformin: from pharmacology to clinical use for women's health
Genazzani, A. D., Ricchieri, F., Prati, A., Chierchia, E., Rattighieri, E., Bosco, G., Despini, G., Campedelli, A., Farinetti, A., & Santagni, S. (2012) · IRIS UNIMORE (University of Modena and Reggio Emilia) · Cited by 3
Identify underlying cause of hirsutism and individualize treatment as required
Writers, A. M. (2014) · Drugs & Therapy Perspectives · doi:10.1007/s40267-014-0159-8 · Cited by 3
Non-contraceptive Benefits of Hormonal Methods
Seracchioli, R., Forno, S. D., & Esposti, E. D. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_10 · Cited by 3
Bridges, N. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_382 · Cited by 2
Rabe, T., Albring, C., Blume‐Peytavi, U., Egarter, C., Geisthövel, F., König, K., Kühl, H., Merkle, E., Ao, M., Reisch, N., et al. (2015) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_40 · Cited by 2
IMPORTANCE OF HAIR GROWTH IN HISUTISM: DIAGNOSIS AND TREATMENT
AANCHHAL, MEHRA, R., Barwal, A., & Gautam, S. P. (2021) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2021v13i6.1914 · Cited by 2
PCOS and Insulin Resistance (IR): From Lifestyle to Insulin Sensitizers
Genazzani, A. D., Santagni, S., Rattighieri, E., Chierchia, E., Despini, G., Prati, A., & Ricchieri, F. (2014) · ISGE series · doi:10.1007/978-3-319-09662-9_2 · Cited by 2
Yaşa, C., Dural, Ö., Baştu, E., & Uğurlucan, F. G. (2016) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2016.613 · Cited by 2
Fonseka, S., Subhani, B., Alahakoon, V., Wijeyaratne, C., Gawarammana, I., Kalupahana, N., Ratnatunga, N., Rosairo, S., & Kumarasiri, P. (2019) · Archives of Psychiatry and Mental Health · doi:10.29328/journal.apmh.1001007 · Cited by 1
Experience of using drospirenone/ethinyl estradiol combination in women of reproductive age
Iurova, M. V., Mezhevitinova, E. A., & Abakarova, P. R. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-113 · Cited by 1
Síndrome do ovário policístico e metformina: revisão baseada em evidências
Ariê, W. M. Y., da Fonseca, Â. M., Bagnoli, V. R., Fassolas, G., & Baracat, E. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Role of Insulin-Sensitizing Drugs in PCOS Management
Awwad, J. T., & Ghazeeri, G. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_10 · Cited by 1
The Relationship between Clinical and Chemical Hyperandrogenism in 14-18-Years- Old Girls
Akbarzadeh, M., Naderi, T., Dabbaghmanesh, M. H., Tabatabaee, H., & Zareh, Z. (2012) · Zahedan Journal of Research in Medical Sciences · Cited by 1
[Evidence-based therapy of polycystic ovarian syndrome].
Gődény, S., & Csenteri, O. K. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30253
Sornalingam, S., & Cooper, M. (2014) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738014521170 · Cited by 1
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17002-2_40-1 · Cited by 1
Zahoor, I., Singh, S., Sharma, N., Grewal, I. K., & Wani, S. N. (2023) · Pharmaceutical Sciences · doi:10.34172/ps.2023.24 · Cited by 1
Metadata
- Authors
- Cosma, M., Swiglo, B. A., Flynn, D. N., Kurtz, D. M., LaBella, M. L., Mullan, R. J., Elamin, M. B., Erwin, P. J., & Montori, V. M.
- Affiliations
- Mayo Clinic (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-04
- Volume
- 93
- Issue
- 4
- Pages
- 1135-1142
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2103374510
- Cited by
- 129
- References
- 36
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 9 · 2014: 12 · 2013: 13 · 2012: 8
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hirsutism, insulin sensitizers, metformin, thiazolidinediones, hyperandrogenism, Ferriman-Gallwey score, oral contraceptives, spironolactone, flutamide, treatment efficacy
- MeSH terms
- Androgen Antagonists, Drug Therapy, Combination, Hirsutism, Humans, Hypoglycemic Agents, Metformin, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review